SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-088963
Filing Date
2016-03-18
Accepted
2016-03-18 17:07:37
Documents
4
Period of Report
2016-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v434700_8k.htm 8-K 21681
2 EXHIBIT 10.1 v434700_ex10-1.htm EX-10.1 121970
3 EXHIBIT 99.1 v434700_ex99-1.htm EX-99.1 17469
4 GRAPHIC image_002.jpg GRAPHIC 13215
  Complete submission text file 0001144204-16-088963.txt   180728
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 161516822
SIC: 2835 In Vitro & In Vivo Diagnostic Substances